Human milk oligosaccharides (HMO) helps in maintaining infant’s gut microbiota as well as promotes the growth of healthy bacteria and reduce pathogens, preventing infections and others bacterial risks. In recent past, sales of infant nutrition products have increased to a significant extent owing to the continuously rising infant population across the globe. According to WHO, the total world population is estimated to increase by approximately one billion in the next 10 years and will reach 9.5 billion by 2050. Incidentally, demand has been relatively higher to the supply of infant nutrition products. Meanwhile, sales of infant formula are also surging in some of the Asian countries such as China and India, promoting the consumption of HMO alike. Future Market Insights’ latest report reveals that the global human milk oligosaccharides market is set to surpass a valuation of US$ 76 Mn, registering a CAGR of 14.6% between 2017 and 2027. This growth will be primarily orchestrated by the increasing application of HMO in infant nutrition products.
For more insights into the market, request a sample of this report@https://www.futuremarketinsights.com/reports/sample/rep-gb-4252
Asia Pacific is expected to be a key market in the global human milk oligosaccharides market. Due to increasing awareness among consumers regarding infant nutrition and increasing population, demand for 2-fucosyllactose as the solution for infant nutritional care is expected to be high in countries such as India and China. Furthermore, new end-use companies are also surfacing in the region. Human milk oligosaccharides manufacturing companies are focussing on investing in research and development for developing a variety of human milk oligosaccharides for application as an ingredient in infant formulas. In a new report titled “Human Milk Oligosaccharides Market: Global Industry Analysis and Opportunity Assessment, 2017-2027,” Future Market Insights presents deep insights into the global human milk oligosaccharides market over a 10 year forecast period. According to the report findings, an increasing demand for functional food and beverage products owing to increasing awareness among consumers about the health benefits from consumption of such products is a factor expected to drive growth in terms of value of the human milk oligosaccharides market over the forecast period. This increasing demand is prompting manufacturers to produce ingredients such as human milk oligosaccharides for application in functional food and beverages.
Human milk oligosaccharides (HMO) is a better alternative for non-lactating mothers as it has all the nutrients required by infants for normal growth. Manufacturers are producing HMOs by various chemical synthesis and fermentation processes in order to cater to the demand for infant formula ingredients. According to the WHO, the total world population is estimated to increase by approximately one billion in the next 10 years and reach 9.5 billion by 2050.
Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-4252
By Product Type
- LNT & LNnT
- North America
- Asia Pacific
Buy Complete Report @https://www.futuremarketinsights.com/checkout/4252
Table Of Content
2. Assumptions and Acronyms
3. Market Introduction
4. Market Dynamics
5. North America Human Milk Oligosaccharides Market Value Analysis, 2017–2027
6. Europe Human Milk Oligosaccharides Market Value Analysis, 2017–2027
7. Asia Pacific Human Milk Oligosaccharides Market Value Analysis, 2017–2027
8. Global Human Milk Oligosaccharides Market Analysis
9. Competition Landscape
10. Company Profile
11. Research Methodology